Patent · US Active

Feedback prodrug

US8796229B2 · kind B2 · utility

0Cited by

3References

8Claims

0Family size

Assignee

University of Georgia Research Foundation, Inc. · US

Inventors

Geert-Jan Boons · Athens, US
Jun Guo · Athens, US

Key dates

Filing date	Aug 31, 2011
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Dec 19, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and methods for use in selectively inhibiting a lytic enzyme based on feedback inhibition are described. The conjugated compound serves as a substrate for a lytic enzyme. Cleavage of the conjugated compound by the lytic enzyme releases an inhibitor of the enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.